Michael R. McDonnell - 07 Feb 2025 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
EVP, Chief Financial Officer
Signature
/s/ Samuel Ntonme, attorney-in-fact for Michael McDonnell
Issuer symbol
BIIB
Transactions as of
07 Feb 2025
Net transactions value
-$212,308
Form type
4
Filing time
10 Feb 2025, 18:59:01 UTC
Previous filing
20 May 2024
Next filing
12 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +2,335 +12% $0.000000 21,741 07 Feb 2025 Direct
transaction BIIB Common Stock Tax liability $111,101 -786 -3.6% $141.35 20,955 07 Feb 2025 Direct
transaction BIIB Common Stock Options Exercise $0 +2,216 +11% $0.000000 23,171 07 Feb 2025 Direct
transaction BIIB Common Stock Tax liability $101,207 -716 -3.1% $141.35 22,455 07 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -2,335 -50% $0.000000 2,335 07 Feb 2025 Common Stock 2,335 $0.000000 Direct F1
transaction BIIB Restricted Stock Unit Options Exercise $0 -2,216 -33% $0.000000 4,434 07 Feb 2025 Common Stock 2,216 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/8/2023.
F2 The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.